Company / Cost of Revenue
USANA HEALTH SCIENCES INC Cost of Revenue History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$176.7M
FY2025
5-year range
$176.7M / $209.1M
FY2021-FY2025
Trend
-8.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has fluctuated over the past 10 years, ranging from $116M in FY2014 to $209M in FY2022.
Based on SEC 10-K filings.
$177M in FY2025 with a 10-year CAGR of +3.3%.
Improved from $209M to $177M over the past 3 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -5.5%
- 5-Year CAGR
- -2.5%
- 10-Year CAGR
- +3.3%
Key checks
Key Insights
- 5-year CAGR of -2.5%, indicating a declining trend.
- In FY2025, cost of revenue decreased 8.9% year-over-year.
- Peak cost of revenue was recorded in FY2022.
- Lowest cost of revenue in the period was in FY2014.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $176.7M | -8.9% |
| FY2023 | $193.9M | -7.3% |
| FY2022 | $209.1M | +4.2% |
| FY2020 | $200.7M | +11.9% |
| FY2019 | $179.4M | -0.4% |
| FY2018 | $180.2M | +12.8% |
| FY2017 | $159.7M | +13.4% |
| FY2016 | $140.8M | +10.5% |
| FY2015 | $127.4M | +10.0% |
| FY2014 | $115.8M | +13.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026